The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 07, 2024

Filed:

Sep. 23, 2020
Applicant:

University Industry Foundation, Yonsei University Wonju Campus, Wonju-si, KR;

Inventors:

Inho Choi, Wonju-si, KR;

Chan-Moon Chung, Yonsei University Gangwon-do, KR;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61P 21/00 (2006.01); A61K 31/137 (2006.01); A61K 31/7076 (2006.01); A61K 33/04 (2006.01); A61K 38/08 (2019.01);
U.S. Cl.
CPC ...
A61K 31/137 (2013.01); A61P 21/00 (2018.01); A61K 31/7076 (2013.01); A61K 33/04 (2013.01); A61K 38/08 (2013.01);
Abstract

A muscular atrophy-inducing agent containing, as an active ingredient, a hypometabolism-inducing substance selected from the group consisting of 3-iodothyronamine (T1AM), [D-Ala2,D-Leu5] enkephalin (DADLE), 5′-adenosine monophosphate (5′-AMP), and hydrogen sulfide (HS), and a method for preventing or treating muscular hypertrophy; and a method for shrinking facial muscle are proposed. The muscular atrophy study model can provide a study model for an economic muscular atrophy study by using a hypometabolism-inducing substance which can be mass-produced, has an effect which may be usefully used by verification for screening of a drug for preventing or treating muscular atrophy, and can be usefully used as a compositions for preventing or treating muscular hypertrophy and a composition for facial muscle shrinkage through the muscular atrophy effect.


Find Patent Forward Citations

Choi, Inho. (2024). Muscular atrophy-inducing agent using hypometabolism-inducing substance t1am, and use thereof in treating muscular hypertrophy (U.S. Patent No. 11974970). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11974970

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…